Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque Psoriasis
NCT05078567 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2021-10-14
Summary
Psoriasis is a chronic and immune mediated skin disorder that presents with plaques of thickened, scaly skin. Up to 71% patients suffer from psoriasis, leading to high impact on their daily life. Plaque psoriasis is the most common type which causes thick, scaly patches of skin. Although the treatment of moderate-to-severe psoriasis has been improved with the new launched biologics, topical therapies continue to play a key role in the management of mild-to-moderate psoriasis. Up to 80% of patients of psoriasis use topical agents as their first-line therapy, including topical vitamin D analogs, corticosteroids, vitamin A analogs, and anthralin. There are well-documented concerns and limitations with current topical treatments. In this study, we propose a nature lactic acid enriched cream with a high safety profile as an alternative choice for patients with plaque psoriasis. Lactic acid is a natural moisturizing factor, which exists in healthy skin. It can efficiently prevent water loss from the skin and alleviate allergic reactions caused by dry skin. The moisturized function of lactic acid has made it became a commonly used additive in a wide variety of skincare products, such as lotion, cream, butter and spray. This product is rich in natural lactic acid generated by the fermentation of probiotics, and therefore can relieve skin itching caused by skin dryness, and resume the water-holding capability of the skin by removing abnormally proliferative stratum corneum as well as inducing collagen production. Importantly, this product is a steroid-free product with safety and without any induced adverse effects in use. This product is also can be a promising option other than steroids to be applied for the mitigation of recurrent symptoms in plaque psoriasis by resuming the water-retention ability of skin and rebuilding skin barrier function.
Conditions
Interventions
- DEVICE
-
5% Natural Lactic Acid-enriched Cream
The subjects were required to topically apply natural lactic acid-enriched cream twice daily in the morning and evening for the treatment duration of 12 weeks.
Sponsors & Collaborators
-
Microbio Co Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-31
- Primary Completion
- 2022-03-31
- Completion
- 2022-04-30
More Related Trials
-
Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis
NCT01205880 ·Status: COMPLETED ·Phase: PHASE4
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
CT 327 in the Treatment of Psoriasis Vulgaris
NCT00995969 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis
NCT01012713 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
NCT06357221 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris
NCT01043224 ·Status: COMPLETED ·Phase: PHASE1
-
LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis
NCT00705900 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
NCT00852761 ·Status: COMPLETED ·Phase: PHASE4
-
Valchlor in the Treatment of Lichen Planopilaris
NCT03417141 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02445807 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris
NCT01268527 ·Status: COMPLETED ·Phase: PHASE2
-
Cromoglicate in Psoriasis
NCT01722812 ·Status: COMPLETED ·Phase: PHASE2
-
Etanercept With Tacrolimus for Psoriasis
NCT00134394 ·Status: COMPLETED ·Phase: PHASE2
-
Microneedle Patch for Psoriatic Plaques
NCT02955576 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination Ointment
NCT05330936 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
NCT01938599 ·Status: COMPLETED ·Phase: PHASE2
-
Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis
NCT02999776 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris
NCT05254249 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914 ·Status: COMPLETED
-
NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study
NCT00708851 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
NCT04594928 ·Status: COMPLETED ·Phase: PHASE1
-
SHP-141C in Plaque Type Psoriasis
NCT01646567 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris
NCT01465282 ·Status: COMPLETED ·Phase: PHASE2
-
Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications
NCT00427609 ·Status: TERMINATED ·Phase: PHASE2